Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors

In our study group of Thai PLT apheresis donors, we assessed the prevalence of anti‐leucocyte antibodies.

[1]  P. Bugert,et al.  Granulocyte antibodies in male blood donors: can they trigger transfusion‐related acute lung injury? , 2018, Transfusion.

[2]  J. Bordin,et al.  Antibodies to human neutrophil antigen HNA‐3b implicated in cases of neonatal alloimmune neutropenia , 2018, Transfusion.

[3]  H. Li,et al.  The prevalence of leucocyte alloantibodies in blood donors from South China , 2015, Transfusion medicine.

[4]  V. Compernolle,et al.  Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy , 2014, Transfusion.

[5]  A. Buser,et al.  Anti‐leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention , 2013, Vox sanguinis.

[6]  P. J. Norris,et al.  Measures to prevent transfusion‐related acute lung injury (TRALI) , 2012, Vox sanguinis.

[7]  C. Chapman,et al.  Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines , 2012, Vox sanguinis.

[8]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[9]  Y. Ozier,et al.  Transfusion‐related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008 , 2011, Transfusion.

[10]  H. Vrielink,et al.  Prevalence of leucocyte antibodies in the Dutch donor population , 2011, Vox sanguinis.

[11]  S. Glynn,et al.  The frequency and specificity of human neutrophil antigen antibodies in a blood donor population , 2011, Transfusion.

[12]  A. Greinacher,et al.  Geno‐ and phenotyping and immunogenicity of HNA‐3 , 2011, Transfusion.

[13]  M. Satake,et al.  Relationship of donor HLA antibody strength to the development of transfusion‐related acute lung injury , 2010, Transfusion.

[14]  S. Kleinman,et al.  Identification of specificities of antibodies against human leukocyte antigens in blood donors , 2010, Transfusion.

[15]  A. Romphruk,et al.  HLA class I and II alleles and haplotypes in ethnic Northeast Thais. , 2010, Tissue antigens.

[16]  C. Hillyer,et al.  Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors , 2010, Transfusion.

[17]  E. Beckers,et al.  Transfusion‐related acute lung injury reports in the Netherlands: an observational study , 2010, Transfusion.

[18]  C. Silliman,et al.  Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. , 2009, Blood reviews.

[19]  C. Hillyer,et al.  The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion‐related acute lung injury risk reduction strategy , 2009, Transfusion.

[20]  P. Stastny,et al.  The role of major histocompatibility complex class I chain-related gene A antibodies in organ transplantation , 2009, Current opinion in organ transplantation.

[21]  P. Bierling.  [Transfusion of platelet concentrates]. , 2009, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[22]  S. Saidman,et al.  Testing only donors with a prior history of pregnancy or transfusion is a logical and cost‐effective transfusion‐related acute lung injury prevention strategy , 2008, Transfusion.

[23]  B. Keller-Stanislawski,et al.  Specificities of leucocyte alloantibodies in transfusion‐related acute lung injury and results of leucocyte antibody screening of blood donors , 2008, Vox sanguinis.

[24]  P. Terasaki,et al.  “Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males , 2008, Transplantation.

[25]  J. Nowak,et al.  Leucocyte antibodies in blood donors and a look back on recipients of their blood components , 2007, Vox sanguinis.

[26]  R. Benjamin,et al.  Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross , 2007, Transfusion.

[27]  U. Sachs,et al.  The pathogenesis of transfusion‐related acute lung injury (TRALI) , 2007, British journal of haematology.

[28]  C. Silliman,et al.  Transfusion-related acute lung injury. , 2005, Blood.

[29]  Jürgen Neppert,et al.  Re: Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2005, Transfusion.

[30]  Robertson Davenport,et al.  Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2004, Transfusion.

[31]  Peter A Lachenbruch,et al.  Fatalities caused by TRALI. , 2004, Transfusion medicine reviews.

[32]  R. Aster,et al.  TRALI due to granulocyte‐agglutinating human neutrophil antigen‐3a (5b) alloantibodies in donor plasma: a report of 2 fatalities , 2003, Transfusion.

[33]  P. Holland,et al.  TRALI: correlation of antigen‐antibody and monocyte activation in donor‐recipient pairs , 2003, Transfusion.

[34]  L. Cooling.  Transfusion-related acute lung injury. , 2002, JAMA.

[35]  B. Flesch,et al.  Transfusion‐related acute lung injury caused by human leucocyte antigen class II antibody , 2002, British journal of haematology.

[36]  P. Holland,et al.  HLA class II antibodies in transfusion‐related acute lung injury , 2001, Transfusion.

[37]  K. Maślanka,et al.  The risk of antibody formation against HNA1a and HNA1b granulocyte antigens during pregnancy and its relation to neonatal neutropenia , 2001, Transfusion medicine.

[38]  Jerzy K. Kulski,et al.  Phylogenetic analysis of penguin (Spheniscidae) species based on sequence variation in MHC class II genes , 2001, Immunogenetics.

[39]  H. Inoko,et al.  Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais. , 2001, Tissue antigens.

[40]  J. Ernerudh,et al.  A randomized controlled trial oftransfusion‐related acute lung injury: is plasma from multiparous blood donors dangerous? , 2001, Transfusion.

[41]  C. Rieux,et al.  [Transfusion of platelet concentrates]. , 1999, Annales de medecine interne.

[42]  W. A. Zellmer.  Toward understanding. , 1988, American journal of hospital pharmacy.

[43]  S. Moore,et al.  Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. , 2015, The American review of respiratory disease.